hodgkin's antigens-gm-csf-expressing cell vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT00134082)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hodgkin's antigens-gm-csf-expressing cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00478062 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2007 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00134082 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2005 | Johns Hopkins University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 2 | 2 | 1 | 2005 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1